This document describes four quantitative methods for efficacy evaluation: bactericidal, mycobactericidal, fungicidal and virucidal. Regulatory authorities have relied upon efficacy data generated using these methods to authorise the placing of biocidal products on the market.
Chinese, PDF, 369kb
These guidelines aim to strike a balance between risk and benefit by drawing the attention of those at the top of industry to the need for high standards of corporate governance in relation to the management of high hazard industries. Chinese version.
Norwegian, PDF, 2,575kb
These guidelines aim to strike a balance between risk and benefit by drawing the attention of those at the top of industry to the need for high standards of corporate governance in relation to the management of high hazard industries. Norwegian version.
English, PDF, 275kb
Global Portal to Information on Chemical Substances, is to be the preferred worldwide source of information about chemicals from authorities and international organisations.
The objective of the Guidance Document is to provide guidance on how to interpret the outcome of individual tests and how to increase evidence on whether or not a substance may be an endocrine disrupter. However, testing strategies or guidance on interpretation from a suite of tests are not given.
This guidance document intends to provide an insight into which pieces of information that are necessary to identify and document an adverse outcome pathway (AOP) and how to present them. The AOP concept has been developed as a means of providing transparent mechanistic justification and weight-of-evidence to reduce uncertainty in the predictions for complex toxicological endpoints.
This document provides guidance for performing an exposure assessment based on environmental monitoring data.It covers topics such as environmental levels and distribution of contaminants, ways of using monitoring data in exposure assessments for differing purposes, the collection of data, quality of monitoring activities, as well as several examples of data compilation in member countries and their use in exposure assessment.
Malaysia has joined the OECD system for the Mutual Acceptance of Data (MAD) in the Assessment of Chemicals, ensuring that its non-clinical safety data related to the protection of human health and the environment will be accepted by all 40 countries adhering to MAD.
This document compares sectors of industrial activities and their reporting thresholds among different national / regional PRTRs to improve the comparability of PRTR data, and proposes a harmonised list of sectors.
This document provides information on current/planned activities related to the safety of manufactured nanomaterials in OECD member and non-member countries that attended at the 10th meeting of OECD’s Working Party on Manufactured Nanomaterials (Paris France, 27-29 June 2012).